BioCardia, Inc. (BCDA) vs Bionano Genomics, Inc. (BNGO)

A side-by-side comparison of BioCardia, Inc. and Bionano Genomics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — BCDA vs BNGO

growth of $100 · dividends reinvested · last 8y
BCDA -99.8% (-53.9%/yr)BNGO -100.0% (-62.5%/yr)BCDA compounded faster over this window
Log scale — wide-divergence pair
001101001kStart $1002020202220242026$0$0
BCDA BNGO

BCDA vs BNGO: by the numbers

  • •BNGO is the larger company ($17M vs $16M market cap).
  • •Both run net losses; BCDA's is the smaller (0.00% vs -106.58% net margin).

Metrics side by side

Valuation

MetricBCDABNGO
P/S ratioN/A0.56
P/B ratio5.880.53

Profitability

MetricBCDABNGO
Gross margin0.00%21.95%
Operating margin0.00%-116.95%
Net margin0.00%-106.58%
ROE-271.81%-101.76%
ROIC-273.70%-85.72%

Growth (annualized)

MetricBCDABNGO
Revenue CAGR (5Y)N/A17.97%
Total return CAGR (5Y)-61.39%-78.37%

Frequently asked

How have BCDA and BNGO total returns compared?
Over the past 5 years, BCDA delivered -61.39% and BNGO delivered -78.37% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.